New Clinical Guidance Helps Men With Advanced Erectile Dysfunction Navigate Treatment Choices Before Committing to Surgery

Leading aesthetic medicine practitioners urge men to explore evidence-based regenerative options alongside surgical pathways


LONDON — As awareness of non-surgical treatments for erectile dysfunction continues to grow, a new wave of clinical guidance is helping men with advanced ED make more informed decisions before committing to irreversible surgical intervention.

For men who have exhausted first-line treatments such as PDE5 inhibitors and lifestyle modification, the traditional next step has been penile prosthesis implantation — a procedure with strong long-term satisfaction data, but one that carries significant risks including infection, mechanical failure, and permanent anatomical alteration. Now, practitioners specialising in regenerative medicine are calling attention to an alternative that sits earlier in the treatment pathway: the Priapus Shot, or P-Shot.

The P-Shot uses platelet-rich plasma (PRP) derived from the patient's own blood, delivered via targeted injection to stimulate tissue repair and improve vascular function. Unlike surgical implantation, the procedure requires no general anaesthetic, no hospital admission, and no permanent structural changes. Reported side effects are typically limited to mild bruising and temporary sensitivity changes.

A Question of Timing — and Clinical Standards

Specialists emphasise that the P-Shot is not a like-for-like replacement for surgery in all cases. Men with severe vascular damage or complete loss of erectile function may still be best served by urological surgical assessment. However, for men who retain some residual function, are not yet surgical candidates, or are managing post-prostatectomy ED, regenerative treatment represents a clinically credible option that warrants serious consideration.

Critically, outcomes vary significantly depending on provider standards. PRP preparation protocols, platelet concentration, and delivery technique differ widely across clinics. Practitioners using CE-marked preparation devices and ultrasound-guided injection — within a properly supervised clinical environment — deliver a fundamentally different standard of care from less rigorous providers.

Expert Commentary

Dr Syed Nadeem Abbas, who holds an MSc in Aesthetic Plastic Surgery with Distinction from Queen Mary University London and carries surgical training from Cambridge, Oxford, and the Royal London Hospital, is among the specialists bringing this level of precision to non-surgical men's health treatment in London.

"The biological principles underpinning PRP therapy are well-established across multiple medical disciplines," said Dr Abbas. "What we are seeing now is a more rigorous application of those principles to men's intimate health — and the results, in appropriately selected patients, are genuinely encouraging. The key is honest expectation management and clinical precision in delivery."

Key Facts at a Glance

  • Penile prosthesis surgery carries risks including infection, device failure, and irreversible anatomical change

  • The P-Shot uses the patient's own blood, eliminating allergic reaction risk

  • Recovery following the P-Shot is typically days; surgical recovery is measured in weeks

  • Clinical outcomes from the P-Shot depend heavily on provider technique and preparation standards

  • Men with residual erectile function or those exploring pre-surgical options are considered the strongest candidates for regenerative treatment

About the Treatment

The Priapus Shot (P-Shot) is a non-surgical, in-clinic procedure using platelet-rich plasma to support erectile tissue regeneration and improved blood flow. It is available from qualified practitioners at specialist men's health and aesthetic medicine clinics across the UK.


For media enquiries or to arrange an interview with a specialist, please contact:

Clinc Name: DR SNA Clinic |

Email Address:[email protected] |

Phone Number:+44 7955 836986 |

Clin Website: drsnaclinic.com

Disclaimer: This and other personal blog posts are not reviewed, monitored or endorsed by TalkMarkets. The content is solely the view of the author and TalkMarkets is not responsible for the content of this post in any way. Our curated content which is handpicked by our editorial team may be viewed here.

Comments